N/A
N=46
Breath Analysis Based Disease Biomarkers
Liver Diseases · Liver Cancer · COVID19
Bottom Line
View on ClinicalTrials.gov: NCT04341012 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Breath Volatile Organic Compound Profiles — 11; 35 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Collection of breath sample (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Sep 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Breath Volatile Organic Compound Profiles |
11; 35 | — |
Summary
The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.
Eligibility Criteria
Inclusion Criteria
- Able to provide informed consent
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT04341012). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.